福安药业(300194.SZ)子公司产品纳入国家医保药品目录

Core Viewpoint - Fuan Pharmaceutical's product, Palivizumab injection, has been included in the National Medical Insurance Drug List, which is expected to enhance the company's market position and revenue potential [1] Group 1 - Fuan Pharmaceutical announced that its subsidiary's product, Palivizumab injection, has been added to the National Medical Insurance Drug List [1] - The inclusion in the drug list is part of the notification issued by the National Healthcare Security Administration and the Ministry of Human Resources and Social Security [1]